首页> 外国专利> Bioreactors, SYSTEMS AND METHODS FOR THE PRODUCTION AND / OR RESEARCH BODIES

Bioreactors, SYSTEMS AND METHODS FOR THE PRODUCTION AND / OR RESEARCH BODIES

机译:用于生产和/或研究机构的生物反应器,系统和方法

摘要

1. Bioreactor comprising;chamber;a first inlet and a first outlet fluidly connected to the chamber, and;a support structure for the body.;2. A kit comprising reagents for stimulating growth and reagents, where the reagents for growth are sufficient to support growth of the replacement body and the bioreactor stimulating reagents are suitable for the stimulation of one or more physiological responses organ-substitute.;3. A method for evaluating organ-substitute for transplantation, the method comprising:;definition ex vivo whether a body substitute one or more functional properties that are physiologically suitable for transplantation to a recipient.;4. A method of estimating a multicellular tissue, the method comprising:;definition ex vivo whether a multicellular tissue, one or more predetermined properties.;5. A method for determining whether a body substitute one or more functional or structural properties that are physiologically suitable for transplantation to a recipient, wherein the one or more structural properties assessed using magnetic resonance imaging, computerized axial tomography, positron emission tomography, X-ray analysis analysis or ultrasonic, or other non-penetrating via technology.;6. A method for evaluating organ-substitute, the method comprises determining the level of one or more physiological parameters of the recipient organ during organ growth ex vivo.;7. A method for evaluating organ-substitute ex vivoThe method comprises determining the level of functional properties of the replacement body with the radiopharmaceutical introduced into the body in the growth chamber.;8. A method for evaluating organ-substitute ex vivo, The method comprises determining the structural and / or functional properties of the replacement body using magnetic resonance imaging, computerized axial tomography, positron emission tomography, ultrasound or x-ray diffraction analysis or by analyzing other body penetrating in a growth chamber.;9. A method of assessing organ-substitute, the method comprises determining the substitute organ vascularization ex vivo.;10. A method for evaluating organ-substitute, the method comprises determining the blood flow within the organ-substitute ex vivo.;11. A method for evaluating organ-substitute, the method comprises determining the oxygen level within the organ-substitute ex vivo.;12. A method for evaluating organ-substitute, the method comprises determining the level of one or more physiological parameters in the set of recipient body points during organ growth ex vivo, and comparing the physiological parameter at each time point with a reference parameter for a given time, which is indicative of a healthy organ-substitute at the end of organ growth.;13. A method for determining a reference level of the physiological parameter at a predetermined time during body growth, which indicates the end of a healthy body organ growth, the method comprising for each of several artificial / synthetic / bodies made substitutes:;Analysis physiological parameter in a plurality of predetermined time points during body growth;;determination of body condition at the end of body growth; and;determining for each time physiological parameter levels that are associated with the levels of the healthy body of physiological parameters that are related to unhealthy body organ at the end of growth.;14. A method for determining the level of a physiological parameter which indicates the end of body growth.;15. A method for verifying that the entity is compatible with the substitute organ recipient before transplantation, the method comprising:;defining features of the first organ-substitute ex vivo.;determining a second aspect of the body of the recipient, and;transplantation of artificial / synthetic / manufactured organ recipient organ, if the first and second features are the same.;16. A method for verifying that the entity is compatible with the substitute organ recipient before transplantation, the method comprising:;labeled cells derived from the recipient's body by the first tag identifier,;growing body of substitute with the labeled cells to generate organ-substitute, a tagged first tag identifier,;confirmation that the first label identifier coincides with the organ recipient before the transplantation of artificial / synthetic / substitute-made body organ recipient.;17. A method for verifying that the entity is compatible with the substitute organ recipient before transplantation, the method comprising:;determining a first physical or chemical characteristics of the organ-substitute ex vivo.;determining a second physical or chemical features of the body of the recipient, and;transplantation of artificial / synthetic / organ-substitute produced organ recipient, if the first and second compatible physiological characteristics, wherein the first and second physiologic characteristics are non-immunological response.;18. The method of organ-substitute cultivation ex vivo, The method comprising:;growing body substitute in a growth chamber at at least a first condition during the first growth period and at a second growth condition for a second time period, wherein the first and second different growth condition.;19. A method for determining the state of at least one part of the examined tissue or organ, comprising:;the location of the infrared detector near the considered tissue or organ;;registering the infrared radiation emitted from the at least one part of a tissue or organ;;specific analysis of infrared radiation and generating data relating to at least one part of a tissue or organ; and;determining the status of at least one part of a tissue or organ, at least partly based on the generated data.;20 is installed on the head unit comprising:;at least two detectors that provide the possibility of orthogonal viewing;;optical observation system WYSIWYG (what you see on screen is what you get);;device with the AF function in real time;;image stabilization controller;;microscope with magnifying capacity of at least 10 ×, at least 15 ×, at least 20 ×, at least 50 ×, at least 100 ×, at least 250 ×, or at least 500 ×;;and Binocular Telescope.
机译:1.一种生物反应器,包括:腔室;流体连接至所述腔室的第一入口和第一出口;以及所述身体的支撑结构; 2。一种试剂盒,包括用于刺激生长的试剂和试剂,其中用于生长的试剂足以支持替代体的生长,并且生物反应器刺激试剂适合于刺激一种或多种生理反应器官替代物; 3。一种用于评估器官替代物的移植方法,该方法包括:定义离体是否替代了生理上适合移植至受体的一种或多种功能特性。一种估计多细胞组织的方法,该方法包括:定义是否多细胞组织具有一个或多个预定特性。一种确定身体是否替代生理上适合移植到受体的一个或多个功能或结构特性的方法,其中使用磁共振成像,计算机轴向断层扫描,正电子发射断层扫描,X射线分析来评估一个或多个结构特性分析,超声或其他非穿透技术; 6。一种评估器官替代的方法,该方法包括确定器官体外生长期间受体器官的一个或多个生理参数的水平。; 7。一种评估体内替代器官的方法,该方法包括通过在生长室内将放射性药物引入体内来确定替代体的功能特性水平。一种评估体内替代器官的方法,该方法包括使用磁共振成像,计算机轴向断层扫描,正电子发射断层扫描,超声或X射线确定置换体的结构和/或功能特性衍射分析或通过分析穿透生长室的其他物体; 9。一种评估器官替代的方法,该方法包括确定离体器官的替代血管生成。10。一种用于评估器官替代物的方法,该方法包括确定离体器官替代物中的血流。11。一种评估器官替代物的方法,该方法包括确定离体器官替代物中的氧水平。12。一种评估器官替代的方法,该方法包括确定器官在体外生长期间一组受体身体点中一个或多个生理参数的水平,并将每个时间点的生理参数与给定时间的参考参数,指示在器官生长结束时健康的器官替代物; 13。一种用于在身体生长期间的预定时间确定生理参数参考水平的方法,该水平指示健康的身体器官生长的终点,该方法包括为几种人工/合成/身体制成的替代物:在身体生长期间的多个预定时间点;在身体生长结束时确定身体状况;每次确定与健康身体水平有关的生理参数水平,该生理参数水平与生长结束时不健康的身体器官有关。确定指示身体生长结束的生理参数水平的方法; 15。一种用于在移植之前验证实体与替代器官受体兼容的方法,该方法包括:定义第一器官替代物的特征;确定器官的第二方面如果第一特征和第二特征相同,则进行人工/合成/人工器官的移植; 16。一种在移植前验证实体与替代器官受体兼容的方法,该方法包括:通过第一标签标识符从受体的身体衍生的标记细胞;用标记细胞生长的替代体以产生器官替代物;带标签的第一标签标识符;确认在人工/合成/替代制造的人体器官接受者移植之前第一标签标识符与器官接受者重合; 17。一种用于在移植前验证实体与替代器官受体兼容的方法,该方法包括:确定器官替代物的第一物理或化学特性;确定第二物理或第二物理或化学特性。受者身体的化学特征,以及;如果第一和第二兼容的生理特性,则移植人工/合成/器官替代产生的器官接受者,其中第一和第二生理特征是非免疫应答。所述体外替代器官培养的方法,所述方法包括:在所述第一生长时期中在至少第一条件下并且在第二生长条件下第二次在生长室中生长体代用品。 19.第一和第二不同的生长条件。一种确定被检查的组织或器官的至少一部分状态的方法,包括:红外探测器在所考虑的组织或器官附近的位置;记录从组织或器官的至少一部分发射的红外辐射。器官;红外辐射的特异性分析,并产生与组织或器官的至少一部分有关的数据;至少部分地基于所生成的数据来确定组织或器官的至少一部分的状态。20安装在头部单元上,该头部单元包括:至少两个提供正交观察可能性的检测器;光学观察系统所见即所得(您在屏幕上看到的就是所得到的);;具有AF功能的实时设备;;图像稳定控制器;;放大率至少为10×,至少15×,至少20×的显微镜,至少50倍,至少100倍,至少250倍或至少500倍;以及双筒望远镜。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号